Learn

Asthma is a common, chronic condition affecting nearly 2.8 million people in Australia, and its multi-system impact necessitates a comprehensive and up-to-date approach to patient care. This CPD activity will guide you through the latest evidence-based practices, focusing on the strategic use of triple therapy within a broader management framework.

Healthscope and its Respiratory Physicians have launched a new 4-hour CPD activity, “The Role of Triple Therapy in Respiratory Disease: Asthma,” designed specifically to revisit your understanding of modern asthma management. This course is accredited for Specialists, offering crucial insights for those in fields like cardiology, endocrinology, and rheumatology. By participating, you will gain a deeper understanding of how triple therapy can impact patients with comorbid conditions, helping you to optimise patient care and collaboration across specialties.

Learning Outcomes

1. Review the incidence and prevalence of Asthma in the Australian community
2. Review the multi-system impact of Asthma on patients with the condition
3. Outline current treatment and management regimes for patients with Asthma.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.